These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 22314850)
1. The incidence of advanced breast cancer in the West Midlands, United Kingdom. Autier P; Boniol M Eur J Cancer Prev; 2012 May; 21(3):217-21. PubMed ID: 22314850 [TBL] [Abstract][Full Text] [Related]
2. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. Lynge E APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674 [TBL] [Abstract][Full Text] [Related]
3. Screening histories of invasive breast cancers diagnosed 1989-2006 in the West Midlands, UK: variation with time and impact on 10-year survival. Lawrence G; O'Sullivan E; Kearins O; Tappenden N; Martin K; Wallis M J Med Screen; 2009; 16(4):186-92. PubMed ID: 20054093 [TBL] [Abstract][Full Text] [Related]
4. Triple-negative breast cancer in West Virginia. Abraham J; Flanagan M; Hazard H; Jubelirer S; Tirona MT; Vona-Davis L W V Med J; 2009 Oct; 105 Spec No():54-9. PubMed ID: 19999267 [TBL] [Abstract][Full Text] [Related]
5. Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer. Helvie MA; Chang JT; Hendrick RE; Banerjee M Cancer; 2014 Sep; 120(17):2649-56. PubMed ID: 24840597 [TBL] [Abstract][Full Text] [Related]
6. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Swedish Organised Service Screening Evaluation Group Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585 [TBL] [Abstract][Full Text] [Related]
7. The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States. Schootman M; Jeffe D; Reschke A; Aft R Breast Cancer Res Treat; 2004 Jun; 85(3):219-22. PubMed ID: 15111759 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. Glass AG; Lacey JV; Carreon JD; Hoover RN J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280 [TBL] [Abstract][Full Text] [Related]
9. Why did the breast cancer lymph node status distribution improve in Denmark in the pre-mammography screening period of 1978-1994? Rostgaard K; Vaeth M; Rootzén H; Lynge E Acta Oncol; 2010 Apr; 49(3):313-21. PubMed ID: 20397766 [TBL] [Abstract][Full Text] [Related]
10. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Miller AB; Baines CJ; To T; Wall C CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087 [TBL] [Abstract][Full Text] [Related]
11. Are international differences in breast cancer survival between Australia and the UK present amongst both screen-detected women and non-screen-detected women? survival estimates for women diagnosed in West Midlands and New South Wales 1997-2006. Woods LM; Rachet B; O'Connell DL; Lawrence G; Coleman MP Int J Cancer; 2016 May; 138(10):2404-14. PubMed ID: 26756306 [TBL] [Abstract][Full Text] [Related]
12. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. Autier P; Héry C; Haukka J; Boniol M; Byrnes G J Clin Oncol; 2009 Dec; 27(35):5919-23. PubMed ID: 19884547 [TBL] [Abstract][Full Text] [Related]
13. Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement. Cronin-Fenton DP; Ries LA; Clegg LX; Edwards BK J Natl Cancer Inst; 2007 Jul; 99(13):1044-9. PubMed ID: 17596573 [TBL] [Abstract][Full Text] [Related]
14. Comparison of screening mammography in the United States and the United kingdom. Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948 [TBL] [Abstract][Full Text] [Related]
15. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. McCann J; Stockton D; Day N J Med Screen; 1998; 5(1):42-8. PubMed ID: 9575460 [TBL] [Abstract][Full Text] [Related]
16. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway. Lousdal ML; Kristiansen IS; Møller B; Støvring H Eur J Public Health; 2014 Dec; 24(6):1017-22. PubMed ID: 24596400 [TBL] [Abstract][Full Text] [Related]
17. Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997-2006. Woods LM; Rachet B; O'Connell D; Lawrence G; Coleman MP Int J Cancer; 2016 May; 138(10):2396-403. PubMed ID: 26756181 [TBL] [Abstract][Full Text] [Related]
18. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002). Anderson WF; Jatoi I; Devesa SS Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451 [TBL] [Abstract][Full Text] [Related]
19. [Incidence of breast cancer before and after implementation of mammography screening]. Hofvind S; Sørum R; Haldorsen T; Langmark F Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2935-8. PubMed ID: 17117191 [TBL] [Abstract][Full Text] [Related]
20. Interval cancers in the Dutch breast cancer screening programme. Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]